Related references
Note: Only part of the references are listed.Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study
Piero Barbanti et al.
HEADACHE (2021)
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
Fabrizio Vernieri et al.
JOURNAL OF HEADACHE AND PAIN (2021)
Do anti-CGRP drugs have a role in migraine aura therapy?
Eleonora Matteo et al.
JOURNAL OF NEUROLOGY (2021)
Fremanezumab and its isotype slow propagation rate and shorten cortical recovery period but do not prevent occurrence of cortical spreading depression in rats with compromised blood-brain barrier
Agustin Melo-Carrillo et al.
PAIN (2020)
Central effects of erenumab in migraine patients An event-related functional imaging study
Christian Ziegeler et al.
NEUROLOGY (2020)
Cortical spreading depression as a site of origin for migraine: Role of CGRP
Liesl N. Close et al.
CEPHALALGIA (2019)
Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats
Kirk W. Johnson et al.
CEPHALALGIA (2019)
Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs
Jakob Moller Hansen et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Are Migraine With and Without Aura Really Different Entities?
Zsigmond Tamas Kincses et al.
FRONTIERS IN NEUROLOGY (2019)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Triggers, Protectors, and Predictors in Episodic Migraine
Michael J. Marmura
CURRENT PAIN AND HEADACHE REPORTS (2018)
Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody
Agustin Melo-Carrillo et al.
JOURNAL OF NEUROSCIENCE (2017)
Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
Andrew F. Russo
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Migraine aura: new ideas about cause, classification, and clinical significance
Andrew Charles et al.
CURRENT OPINION IN NEUROLOGY (2015)
Cortical spreading depression and migraine
Andrew C. Charles et al.
NATURE REVIEWS NEUROLOGY (2013)
Migraine and structural changes in the brain A systematic review and meta-analysis
Asma Bashir et al.
NEUROLOGY (2013)
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression
Alessandro Tozzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Activation of Central Trigeminovascular Neurons by Cortical Spreading Depression
XiChun Zhang et al.
ANNALS OF NEUROLOGY (2011)
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
Jakob Moller Hansen et al.
CEPHALALGIA (2010)
Migraine Pain and Nociceptor Activation-Where Do We Stand?
Dan Levy
HEADACHE (2010)
Activation of Meningeal Nociceptors by Cortical Spreading Depression: Implications for Migraine with Aura
XiChun Zhang et al.
JOURNAL OF NEUROSCIENCE (2010)
Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems
W Ma et al.
NEUROSCIENCE (2003)
Mechanisms of migraine aura revealed by functional MRI in human visual cortex
N Hadjikhani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
